Living drugs upend cancer treatment at Tang Prize Masters Forum
At the Tang Prize Masters Forum, Steven Rosenberg, Michel Sadelain, and Carl June showed how engineered immune cells and AI are changing cancer care and autoimmune disease treatment.
Amtagvi 1 article
Amtagvi is the specific therapeutic product associated with lifileucel and autologous tumor-infiltrating lymphocyte therapy. Its biological design brings together TIL cell therapy, melanoma immunotherapy and tumor-derived lymphocytes, while ex vivo T-cell expansion, non-engineered cellular immunotherapy and adoptive cell transfer define the disease, delivery or mechanistic context in which the intervention is understood. That scope preserves Amtagvi as a product-level entity rather than a synonym for autologous tumor-infiltrating lymphocyte therapy.